News | August 03, 2009

Abbott Issues Recall of POWERSAIL Coronary Dilatation Catheters

August 3, 2009 – Abbott is conducting a voluntary recall of its POWERSAIL Coronary Dilatation Catheters, which may be damaged and can cause a leak of contrast material during use, possibly leading to catheter functional failures, including air embolism and myocardial infarction.

The company is recalling three lots from United States distribution and one lot from international distribution as a result of four complaints (one from each lot) that the distal shaft of the catheter exhibited damage. While the issue could be detected and avoided during the preparation for use of the product, the company wanted to withdraw the damaged items to avoid patient safety issues.

Abbott Vascular's sales representatives contacted all customers affected by this action and instructed them to cease use of any units from the part numbers and lot numbers listed below. All outstanding units are in the company's possession or are in transit. Patients who have already been treated are not affected by this action.

Three out of the four complaints of distal shaft damage resulted in no adverse patient effects. One complaint reported that the patient had evidence of a post-procedural myocardial infarction. Subsequently, the patient was reported to be doing well.

The FDA has been apprised of this action, and it has classified this action as a class I recall.

The affected devices can be identified by the part number and lot number combinations shown below:

• POWERSAIL 3.25x18mm (U.S.), 1005524-18, 7101051

• POWERSAIL 4.0x8mm (CE), 1005726-08, 7112051

• POWERSAIL 2.75x18mm (U.S.), 1005522, 8012151

• POWERSAIL 3.25x8mm (U.S.), 1005524-08, 8053061

Customers with questions or concerns should contact their Abbott Vascular Representative or call the company at (800) 227-9902.

For more information:

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters | October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters | August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters | March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters | November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters | July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters | January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init